ENZON PHARMACEUTICALS INC's ticker is ENZN and the CUSIP is 293904108. A total of 75 filers reported holding ENZON PHARMACEUTICALS INC in Q1 2014. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $13,000 | -31.6% | 28,090 | 0.0% | 0.00% | – |
| Q4 2015 | $19,000 | -29.6% | 28,090 | 0.0% | 0.00% | – |
| Q3 2015 | $27,000 | -18.2% | 28,090 | 0.0% | 0.00% | – |
| Q2 2015 | $33,000 | +10.0% | 28,090 | 0.0% | 0.00% | – |
| Q1 2015 | $30,000 | -16.7% | 28,090 | -13.2% | 0.00% | – |
| Q4 2014 | $36,000 | -5.3% | 32,375 | -6.9% | 0.00% | – |
| Q3 2014 | $38,000 | 0.0% | 34,775 | -4.1% | 0.00% | – |
| Q2 2014 | $38,000 | -97.4% | 36,275 | -97.4% | 0.00% | – |
| Q1 2014 | $1,457,000 | -77.4% | 1,414,606 | -41.4% | 0.00% | – |
| Q4 2013 | $6,435,000 | +232.9% | 2,412,830 | +110.1% | 0.00% | – |
| Q3 2013 | $1,933,000 | -21.7% | 1,148,470 | -6.9% | 0.00% | – |
| Q2 2013 | $2,468,000 | – | 1,234,169 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALGERT GLOBAL LLC | 124,891 | $85,000 | 0.04% |
| Icahn Capital | 5,904,863 | $4,030,000 | 0.01% |
| SEIZERT CAPITAL PARTNERS, LLC | 414,810 | $283,000 | 0.01% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 473,708 | $323,000 | 0.01% |
| Anson Funds Management LP | 25,000 | $17,000 | 0.01% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 106,908 | $72,000 | 0.01% |
| Spark Investment Management LLC | 57,500 | $39,000 | 0.01% |
| Renaissance Technologies | 3,501,585 | $2,390,000 | 0.01% |
| Concert Wealth Management Inc. | 45,938 | $30,000 | 0.00% |
| CSS LLC/IL | 96,572 | $66,000 | 0.00% |